|
|
|
Volumn 35, Issue 3 SUPPL. 4, 1998, Pages 13-21
|
|
The clinical pharmacology of topoisomerase I inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 (4 METHYLPIPERAZINOMETHYLENE) 10,11 ETHYLENEDIOXY CAMTOTHECINDIHYDROCHLORIDE;
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
7 ETHYL 10 HYDROXYCAMTOTHECIN;
9 AC;
9 AMINOCAMPTOTHECIN;
CAMPTOTHECIN DERIVATIVE;
CISPLATIN;
DNA TOPOISOMERASE INHIBITOR;
FLUOROURACIL;
IRINOTECAN;
LURTOTECAN;
TOPOTECAN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
DRUG DISTRIBUTION;
DRUG EFFECT;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG STRUCTURE;
HUMAN;
PRIORITY JOURNAL;
REVIEW;
STRUCTURE ANALYSIS;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
CLINICAL TRIALS;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
|
|
EID: 0031697966
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (20)
|
|
References (39)
|
